1.Common Clinical Problems Encountered During TB Chemotherapy.
Tuberculosis and Respiratory Diseases 1999;46(2):161-164
No abstract available.
Drug Therapy*
2.Adverse factors of hepatic dysfunction during chemotherapy for childhood malignancy.
Dong Hoon KOH ; Hyung Jong LIM ; Young Kwon CHOI ; Hoon KOOK ; Tae Joo HWANG
Journal of the Korean Cancer Association 1993;25(3):417-422
No abstract available.
Drug Therapy*
3.Results of 6 month short course chemotherapy for pulmonary tubercul-osis with 2SHRZ/4HR.
Hyong Ju LEE ; Chul Hong MIN ; Sun Woo LEE ; In Won PARK ; Byoung Whui CHOI ; Sung Ho HUE
Tuberculosis and Respiratory Diseases 1991;38(2):93-98
No abstract available.
Drug Therapy*
4.Clinical evaluation of a totally implantable venous access system for long-term anticancer chemotherapy.
Tejune CHUNG ; Won Sang CHUNG ; Young Hak KIM
Journal of the Korean Cancer Association 1991;23(2):424-428
No abstract available.
Drug Therapy*
5.Recent New Trends of Anticancer Drug Therapy.
Journal of the Korean Geriatrics Society 2004;8(3):128-136
No abstract available.
Drug Therapy*
6.A case of simultaneous presentation of symptomatic PCM and MDS unrelated to prior chemotherapy.
Hyerim KIM ; Sang Hyuk PARK ; Eun Yup LEE ; Moo Kon SONG
Blood Research 2015;50(3):179-181
No abstract available.
Drug Therapy*
7.Complications of early postoperative intraperitoneal chemotherapy.
Journal of the Korean Cancer Association 1991;23(4):821-827
No abstract available.
Drug Therapy*
8.Individualization of drug therapy: an historical perspective.
Translational and Clinical Pharmacology 2014;22(2):52-54
No abstract available.
Drug Therapy*
9.A clinical analysis for indication of intraperitoneal chemotherapy.
Young Tae KIM ; Byeong Ryong SEOL
Journal of the Korean Surgical Society 1993;44(3):414-421
No abstract available.
Drug Therapy*
10.Pathological observations in locally advanced gastric carcinomas after preoperative chemotherapy.
Kyung Ja CHO ; Ja June JANG ; Chang Won HA ; Jae Soo KOH ; Jong In LEE ; Dong Wook CHOI ; Yoon Koo KANG
Journal of the Korean Cancer Association 1992;24(4):541-548
No abstract available.
Drug Therapy*